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2. ABSTRACT 
 
Associations between ambient air pollutants and serum Clara cell protein concentrations 
among elderly men in Oslo, Norway 
 
Author:  
 Kevin L. Durand 
     
Supervisor:  
Dr.Med. Per Nafstad 
 
Co-Supervisors: 
Dr.scient. Per Schwarze 
Cand.Polit. Christian Madsen 
 
Financed in part by The Norwegian Roads Administration 
 
OBJECTIVE:  This study aims to investigate associations between serum Clara cell 
protein concentrations, among a population of elderly men in Oslo, Norway, and 
exposures to ambient air pollutants.  
 
METHODS:  A variety of methods have been used to study the effects of ambient air 
pollution on human health. Recently, a new approach referred to as, 
"pneumoproteinemia" was developed to evaluate the integrity of the pulmonary 
epithelium by measuring the concentration of lung-specific proteins in serum. The 
prototypic pneumoprotein is the 16-kDa Clara cell protein (CC16), an anti-inflammatory 
protein secreted by Clara cells in the respiratory tract and predominantly in terminal 
bronchioles from where it leaks into serum. This study used an enzyme-linked 
immunosorbent assay (ELISA) to determine serum CC16 concentrations for 1200 blood 
samples that were drawn during the Oslo Study II.  
 
RESULTS:  Unadjusted serum CC16 concentrations ranged from 1.2 to 115.2 µg/L with 
a geometric mean of 9.4 µg/L. Statistically significant associations were found between 
serum CC16 concentrations and the following: age; chronic bronchitis and/or 
emphysema; smoking status; number of cigarettes smoked per day; and particulate matter 
(PM10 and PM2.5) exposures (one-week before the basic clinical examination). No 
associations were found between serum CC16 concentrations and the following: 
education level; NO2, PM10, and PM2.5 exposures one-year before the basic clinical 
examination.   
 
There was a 0.2 percent change in serum CC16 concentrations for each one µg/m
3 
change 
in PM10 exposure that occurred one-week before the basic clinical examination. In 
addition, there was a 0.2 percent change in serum CC16 concentrations for each one 
µg/m
3 
change in PM2.5 exposure that occurred one-week before the basic clinical 
examination. These effects remained unchanged after adjusting for age, self-reported 
chronic bronchitis and/or emphysema, smoking status, and number of cigarettes smoked 
per day.   
 
 
 4
CONCLUSIONS:  The findings of this study support other studies that have found 
evidence of associations between serum CC16 concentrations and ambient air pollutants.   
In addition, results of this study are consistent with other studies that have reported small 
but statistically significant increases in adverse respiratory effects as a result of recent 
PM2.5 and PM10 exposures. Lastly, the results indicate that effects of PM2.5 and PM10 
exposures that occurred one-week before the basic clinical examination on serum CC16 
concentrations were less than that of other known factors such as cigarette smoking. 
 
Keywords:  ambient air pollution, cross-sectional study, cigarette smoking, respiratory 
disease, serum Clara cell protein (CC16). 
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3. BACKGROUND AND SIGNIFICANCE 
 
 During the first half of the 20th century, the effects of ambient air pollution on 
human health became apparent in Europe and the United States after thousands of people 
were inadvertently exposed to extremely high levels of ambient air pollutants. The most 
severe episodes occurred in the Meuse Valley, Belgium, in 1930; Donora, Pennsylvania, 
in 1948; and London, in 1952 (1-3). Dramatic increases in morbidity and mortality were 
observed during each of the episodes. Subsequently, clean air legislation and regulatory 
actions led to reductions in ambient air pollution in many regions of the world. However, 
recent epidemiological studies that are utilizing more sophisticated research tools such as 
biomarkers, geospatial technology, and advanced statistical methods have identified 
serious health effects of ambient air pollution even at the low concentrations that are 
typical of most Western industrialized cities. A number of these studies, mostly 
conducted in Western Europe and the United States, have documented acute and chronic 
effects of ambient air pollutants on the human cardiopulmonary system (4). At the same 
time, people living in rapidly expanding megacities in Asia, Africa, and Latin America 
are increasingly being exposed to rising levels of ambient air pollution that rival and 
often exceed those experienced in industrialized countries during the first half of the 20th 
century (5, 6).  
  Recently the World Health Organization's Global Burden of Disease Initiative 
has estimated that ambient air pollution causes about five percent of trachea, bronchus 
and lung cancer, two percent of cardiorespiratory mortality and about one percent of 
respiratory infections mortality globally. This amounts to about 800,000 premature deaths 
and 6.4 million years of life lost annually, with the burden of disease occurring 
predominantly in the developing countries of Asia (7, 8). It is important to understand 
that these estimates only consider the impact of ambient air pollution on mortality, and 
not morbidity, due to the dearth of epidemiological data. The current body of evidence 
indicates that ambient air pollution is linked to increases in illness, utilization of health 
care services, and premature death among exposed populations. (7-12). 
 The aim of this thesis project is to investigate associations between serum Clara 
cell protein (CC16) concentrations and exposures to ambient air pollutants. Clara cell 
protein is a relatively new biomarker that has the potential to detect acute and chronic 
lung epithelium damage. First, I present a review of the relevant methods that have been 
used to explore the effects of ambient air pollution on human health. 
 6
Comprehensive and Critical Review of Relevant Research Methods 
Historical observations of severe ambient air pollution episodes 
 
 The earliest and most methodologically simple studies evaluated daily variation in 
mortality induced by extreme levels of ambient air pollution. Although there have been a 
number of documented events where extreme levels of ambient air pollution have led to 
increased morbidity and mortality rates, three severe episodes during the middle of the 
20
th
 century are among the most intensively studied; Meuse Valley, Donora, and London.  
The observations from these historical events were mainly used to compare death counts 
over periods of several days or weeks before, during, and after the episodes. Each of 
these episodes provided valuable information for drawing attention to the hazards of 
ambient air pollution and for generating hypotheses. However, information from these 
episodes could not be used to determine cause and effect relationships or assess 
confounding due to the scarcity of individual level data. Even so, observations from these 
episodes provided indisputable evidence that extreme levels of ambient air pollution have 
important acute effects on human health (13). Subsequently, national and international 
organizations formulated air quality guidelines and standards based on information from 
previous episodes of severe ambient air pollution. The initial legal and other corrective 
measures contributed to a decrease in ambient air pollution to moderate or low levels in 
many Western countries (14). However, these legal and other corrective measures mainly 
focused on reducing air pollution by setting emission standards for stationary sources 
such as power plants and steel mills. They did not take into account mobile sources of air 
pollution, which has increasingly become a major source of ambient air pollution.  
 
Time- series studies 
 
 In the 1970s and 1980s, time-series studies were conducted which collected daily 
mortality and ambient air pollution data from a single city or community for several years 
and analyzed correlations in the data (15). An advantage of the time-series study design is 
that it does not require episodes of extreme ambient air pollution, and allows for 
evaluation of potential mortality effects of relatively low, more typical levels of ambient 
air pollution. In addition, time-series studies tend to be much less expensive than  
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prospective cohort studies. However, time-series studies often fail to capture the chronic 
health effects of long-term exposure to ambient air pollution. Correlations between daily 
mortality and ambient air pollution have been observed, but past time-series studies have 
been hampered by insufficient ambient air pollution data and inadequate statistical 
methods. In the 1990s, results from several time-series studies that utilized more rigorous 
statistical modeling techniques were published (16-24). The primary statistical approach 
was time-series modeling of count data using Poisson regression. The results from these 
studies indicated a significant association between daily mortality counts and ambient air 
pollution, even at levels well below the established air quality standards. 
      Although time-series studies have revealed significant associations between 
elevated mortality and short-term exposure to ambient air pollution, a recently discovered 
programming error has called into question the results of many of these analyses (25), 
leaving government regulators and others wondering about the magnitude and validity of 
the association (26). However, results from an extensive re-analysis of a previous time-
series study corroborated with results from the original analysis (27). Even so, compared 
with randomized controlled experimental studies in which the investigator controls the 
intervention, findings from time-series analyses are susceptible to uncontrolled biases and 
must therefore be interpreted cautiously. There have been a lot of questions and concerns 
about the inherent limitations of time-series studies, including: the repeatability of results; 
whether the observed associations are due to biased analytic approaches or statistical 
modeling techniques; whether associations are due to confounding because of inadequate 
control of long-term time trends, seasonality, weather, or some other pollutant; whether 
associations are biologically significant or plausible; whether statistically significant 
effects of ambient air pollution on human health could be observed at pollution levels 
well below U.S. ambient air quality standards; and whether a threshold level of ambient 
air pollution exists where no health effects are observed below the threshold level.   
      Subsequent research efforts have partially addressed some of the above questions 
and concerns. The results have been largely replicated by other researchers (28), and 
more importantly, similar associations have been observed in many other cities with very 
different climates, weather conditions, and pollution mixtures, as discussed in recent 
reviews (4, 29-34). Furthermore, increasingly rigorous and sophisticated statistical time-
series modeling techniques have also been used to try to better control for potential 
confounders. For example, generalized additive models that use nonparametric  
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smoothing have allowed for highly flexible fitting of seasonality and long-term time 
trends as well as nonlinear associations with weather variables such as temperature and 
humidity (35-37). These nonparametric smoothing approaches have allowed for modeling 
flexible nonlinear exposure-response relationships with air pollution to explore for a no-
effects threshold. A well-defined threshold has generally not been consistently observed.  
The exposure-response relationship between particulate air pollution and mortality has 
generally been near linear. Synoptic weather modeling has also been used in some of the 
studies (37, 38). The air pollution effects generally persisted after controlling for weather 
by either nonparametric smoothing of temperature and humidity or controlling for 
synoptic weather patterns. Moreover, previous time-series analyses have highlighted the 
importance of using multiple methodological perspectives in exploring the effects of 
ambient air pollution on human health. 
 
Prospective cohort studies 
 
Over the years, scientists and policymakers have shown more interest in the 
health effects of long-term ambient air pollution exposure. Most of the studies completed 
to date have used large cohorts with mortality follow-up using Cox regression modeling.  
Although cohort studies are often considered the Gold Standard for assessing the health 
effects associated with long-term ambient air pollution (39), only a handful of cohort 
studies have been conducted. The cohort studies that have explored the relationship 
between long-term ambient air pollution exposure and mortality include: the Harvard Six 
City cohort, the American Cancer Society cohort, the Adventist Health Study cohort, the 
Netherlands Diet and Cancer cohort, the Firestone clinic study, and the more recently 
published Norwegian health study (40-46). Collectively, these cohort studies 
communicate a significant, positive association between long-term exposure to ambient 
air pollution and mortality. Specifically, some have found statistically significant 
associations between ozone (42); sulphur dioxide (43, 44); or nitrogen dioxide (45, 46); 
PM2.5 (41); PM10 (40) and mortality.  
The cohort study design is advantageous when evidence suggests an association 
of a disease with a certain exposure or exposures. In addition, the cohort study design 
facilitates the calculation of incidence rates, minimizes recall bias, and makes it possible 
to study many disease outcomes simultaneously. Although powerful, many of the cohort  
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studies that have studied the health effects of long-term ambient air pollution exposure 
have been criticized for non-representative samples (47), lack of control for ecologic 
confounder (48) at the correct scale (45), short follow-up for assessment of effects (30) 
and inadequate control for spatial autocorrelation (49, 50), which may influence the size 
and statistical significance of the health effects (51). In addition, cohort studies often take 
many years and require many resources. This may partially explain why so few cohort 
studies have been conducted. Nevertheless, results from cohort studies will continue to be 
major sources of data for refining legal and regulatory measures in an effort to account 
for increasing amounts of ambient air pollution from mobile sources. 
 
Cross-sectional studies 
 
With the immediate need for evidence on the effects of ambient air pollution on 
human health and the growing interest in the effects of chronic exposures, cross-sectional 
studies hold great potential for contributing to science and policy. In a cross-sectional 
study design, a sample of reference population is examined at a given point in time. This 
study design can be used to analyze cohort data, in that it consists of taking a "snapshot" 
of a cohort by recording information on health outcomes and exposures simultaneously.  
Cross-sectional studies are important for examining associations between exposures and 
outcomes. In addition, cross-sectional studies are useful for comparing the health effects 
of ambient air pollution across several locations at a given time. Also, cross-sectional 
analyses tend to be less expensive and require less time compared to cohort studies.  
Moreover, they have an advantage over time-series analyses in that they can capture both 
acute and chronic effects of ambient air pollution. However, a major constraint of cross-
sectional studies is the need to account for a large number of potentially confounding 
factors, such as differences in age, smoking status, alcohol consumption, environmental 
tobacco smoke exposures, and occupational exposures. In addition, another major 
limitation to the cross-sectional study design is that it is not possible to establish a 
temporal relationship between exposure and outcome. One recent cross-sectional study 
that linked ambient air pollution to mortality in the counties of the US (48) demonstrated 
how this study design can be used to investigate the health effects of chronic exposure.  
The cross-sectional study design will continue to be used since it offers the opportunity to  
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test numerous health determinants to assess how these confound or are confounded by 
exposures to ambient air pollution.  
 
Intervention studies 
  
      Population-based randomized controlled studies of the relationship between 
ambient air pollution and health are unethical. Instead, epidemiologists often take 
advantage of natural experiments or interventions, where sudden changes in exposure 
levels in an area could possibly influence levels of morbidity and mortality. Many 
intervention studies have highlighted the health benefits of improvements in air quality 
and provided useful information to decision-makers and policy-makers. Intervention 
studies have provided strong circumstantial evidence of the health gains from efforts to 
improve air quality. However, these studies are very rare. The few examples that exist 
can be categorized as describing short-term and long-term interventions. 
 
Short-term interventions 
 
One of the classic intervention studies was reported in 1991 (52). The temporary 
closing of a steel mill because of a labor dispute in the Utah Valley during the late 1980s 
provided researchers with a unique opportunity to demonstrate the relationship between 
exposure to particle air pollution and respiratory health. The study assessed the 
association between respiratory hospital admissions and particulate matter (PM10) 
pollution in the Utah, Salt Lake, and Cache valleys during April 1985 through March 
1989. The Utah and Salt Lake valleys had increased PM10 pollution levels, due to 
industrial activities, which violated both the annual and 24-hour standards issued by the 
Environmental Protection Agency (EPA). Much lower PM10 pollution levels occurred in 
the Cache valley. Pope studied the frequency of hospital admissions during the 13 months 
that the steel mill was closed and 16 months before and 19 to 35 months after the strike.  
Bronchitis and asthma admissions for preschool age children were compared between the 
valleys and were found to be approximately twice as frequent in Utah Valley when the 
steel mill was operating versus when it was not. During the period when the steel mill 
was closed for thirteen months because of a strike, differences in per capita admissions 
between Utah and Cache valleys narrowed considerably. During the mill’s  
 11
closure the number of children with respiratory symptoms admitted into hospitals 
decreased substantially and then increased to pre-strike levels when the mill reopened.  
The results from this intervention study suggest that reductions in PM10 pollution from 
industrial sources can improve respiratory health. 
Another study took advantage of the implementation of a modified transport 
strategy, to reduce traffic congestion during the 1996 Summer Olympic Games in 
Atlanta. This intervention study investigated the health impact of a short-term change in 
levels of transport-related air pollution (53). For a total of more than ten weeks (4 weeks 
before, 17 days during and 4 weeks after the Games), data was collected for the 
following: the number of medical emergency visits, the number of hospitalizations for 
asthma and non-asthma events, air quality, weather conditions, and traffic and public 
transportation. The air quality data included measurements of PM10, nitrogen dioxide, and 
ozone. The results of the analysis show a significant decrease in the number (41.6 
percent) and incidence of acute care events for asthma (RR: 0.48, 95 percent CI: 0.44-
0.86) during the Olympic Games. In the same period, air quality improved, with 
significant reductions in ozone (from 163 µg/m
3
 to 117 µg/m
3
 mean of one-hour daily 
maximum), carbon monoxide (from 1.80 mg/m
3
 to 1.47 mg/m
3
, eight-hour means) and 
PM10 (from 36.7 µg/m
3
 to 30.8 µg/m
3
 daily mean) concentrations. In addition, the peak 
weekday morning traffic counts were reduced by 22.5 percent from the baseline period, 
and the peak daily ozone concentration was significantly correlated with traffic counts 
(correlation coefficient r = 0.36). 
The results from the Olympic Games example suggest that reductions in car 
emissions and the associated ozone and PM10 levels, resulting from changes in city 
transportation systems, can prevent disease and lead to a reduced number of asthma 
exacerbations that require medical attention. This study, however, has some noticeable 
weaknesses that should be considered, including low statistical power, a limited number 
of air pollution monitoring sites and a poor traffic counting system. Moreover, due to the 
high correlation between the levels of PM10 and ozone, it is impossible to determine 
which pollutants’ reduction was responsible for the decrease in asthma events, although 
ozone levels were reduced further (28 percent) than PM10 levels (16 percent). However, 
these results support the general opinion that reductions in automobile emissions can 
contribute to the improvement in air quality, which is not necessarily affected so much by 
weather conditions since they remained relatively constant during the observation period.   
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Despite some limitations, the immediate inferences are apparent and highlight the need to 
introduce changes in traffic that improve air quality so the detrimental effects of ambient 
air pollution, generated by mobile sources, on human health can be minimized. 
 
Long-term interventions 
 
 Some intervention studies that assessed the health effect of long-term changes in 
ambient air pollution have been published. There are a variety of long-term changes that 
can be made to reduce the adverse effects of exposures to transport-related ambient air 
pollution on human health. One increasingly used option involves regulating traffic, for 
example, building tunnels, diverting traffic to different routes, constructing roundabouts 
and regulating speed. Environmental evaluation reports often document the impact of 
traffic regulation in terms of changes in ambient air pollution levels, living conditions and 
the well-being of the local residents. However, the number of published studies that 
specifically assess the effects of these types of interventions on human health is very 
limited. 
Two studies have been published in connection with the construction of traffic 
tunnels in Norway. They were constructed to reduce the effect of traffic on the urban 
environment in Oslo. Bartonova et al. (54) used a dispersion model to estimate the effect 
of these changes on the residents’ levels of exposure. After both tunnels were in use, the 
average exposure to nitrogen dioxide decreased from 51 µg/m
3
 to 40 µg/m
3
 (54).  
Another study investigated the effect of the tunnels on the self-reporting of symptoms of 
reduced health and on the well-being of adults living in Oslo (55). The decrease in the 
levels of nitrogen dioxide reported by Clench-Aas et al. (55) was related to a decrease of 
about 5 to 10 percent in the risk of being bothered by fatigue.  
Improvements in technology, such as emission controls or changes in fuel 
composition can also serve as interventions and provide new opportunities for 
epidemiological research to investigate the effects of ambient air pollution on human 
health. In 1990, a fuel restriction was introduced in Hong Kong that required all power 
plants and road vehicles to use fuel oil with a sulfur content of not more than 0.5 percent 
by weight. One study examined the effect of this intervention on immediate and long-
term health benefits. In the first year after introducing this intervention, the mean 
reduction in sulfur dioxide was 53 percent, and this reduction was sustained at 35 to 53  
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percent for five years (56). More importantly, the intervention led to significant declines 
in the average annual trends in deaths from all causes (2.1 percent; p < 0.01), respiratory 
causes (3.9 percent; p < 0.01) and cardiovascular diseases (2.0 percent; p = 0.05).  
Reductions in risks for overall mortality were greater in districts that had large reductions 
in sulfur dioxide than in those that did not. In addition, differences in age-specific death 
rates before and after the intervention suggest that it resulted in an average gain in life 
expectancy of 0.73 years for men aged 25 to 100 years, because of a 10 ug/m
3
 reduction 
in exposure to sulfur dioxide for 15 years (56). 
 More recently, Lou et al. (57) provided additional support for the beneficial 
effects of changes in fuel composition on levels of lead in blood in China. In 1998, 
gasoline stations in the city of Shantou were prohibited from selling leaded gasoline. The 
effects of this intervention on the levels of lead in children’s blood were investigated for 
three consecutive years, when the average levels declined from 104 µg/L in 1999 to 94 
µg/L in 2000 and 79 µg/L in 2001. These decreases were all statistically significant. The 
current standard elevated level of lead in blood for children, which was set by the Centers 
for Disease Control and Prevention in the United States, is 100 µg/L. Lou et al (57) found 
that the percentage of children in Shantou with levels above this standard was reduced by 
35.8 percent in 2000 and 23 percent in 2001. These results indicate that prohibiting the 
sale of leaded gasoline in the city had beneficial effects. Considering the size of the 
transit sector, the implementation of similar regulations in other parts of China should 
help to reduce these numbers even more. However, it is important to be aware of the fact 
that elevated levels of lead in blood can have other sources, although automobile 
emissions from the combustion of leaded gasoline have been recognized as one of the 
major sources of widespread environmental lead contamination.   
 Intervention studies can provide valuable information that aids in understanding 
the effects of ambient air pollution on human health, and in highlighting the observable 
health benefits of air quality legislation and regulation, and the emission sources 
involved. Unfortunately, intervention studies are rare. However, the use of intervention 
studies for elucidating the effects of ambient air pollution on human health should be 
encouraged (58).  
 The short-term intervention studies that have been performed so far suggest that 
reductions in ambient air pollution may have a direct health benefit by reducing acute 
asthma attacks and related medical care. The intervention studies of long-term changes  
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reported several health benefits such as decline average annual trends in deaths from all 
causes and from respiratory and cardiovascular diseases, and a gain in life expectancy.  
However, because of the limited amount of evidence, one needs to be cautious about 
drawing firm conclusions about the health benefits of the particular interventions. 
 
Case-control and Case-crossover studies  
 
The relationship between ambient air pollution and human health has also been 
studied in a few case-control investigations (59-61) and more recently with the use of 
case-crossover studies (62, 63). Case-crossover studies by Neas et al. (62) and Lee and 
Schwartz (63) have provided an interesting alternative approach to analyzing mortality 
effects of short-term exposure to air pollution. Rather than using time-series analysis to 
evaluate associations between daily death counts and air pollution, these two studies 
adapt a common case-control design. This approach matches exposures at the period of 
time of death (case period) with one or more periods when the death did not occur 
(control period) and evaluates potential excess risk using conditional logistic regression.  
Deceased individuals essentially serve as their own controls. By choosing control periods 
on the same day of the week and within one to three weeks of death, this approach 
restructures the analysis such that day of week, seasonality, long-term time trends, and 
changes in population size and composition are dealt with by design rather than by 
statistical modeling. Because this approach focuses on individual deaths rather than death 
counts, there are more opportunities to evaluate factors that may modify or influence the 
mortality effects of air pollution. However, the case-crossover approach has some 
limitations. The results can be sensitive to the selection of control periods, especially 
when clear time trends exist. To overcome this constraint, Neas et al. and Lee and 
Schwartz suggest choosing symmetric control periods both before and after the date of 
death. In addition, the case-crossover approach has lower statistical power due to the loss 
of information from control periods that cannot be included in the analysis. 
The results from these case-crossover studies are in concordance with previous 
studies that explored the effects of ambient air pollution on human health. However, a 
major drawback of these two case-crossover studies is that they do not provide much 
information on biological plausibility or the specific pollutant or mix of pollutants  
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responsible for the observed mortality effects. Recent reviews (4, 29-34) of the overall 
epidemiologic evidence support a probable link between fine combustion-related ambient  
air pollution and cardiopulmonary disease and mortality. In addition, several recent 
studies have reported that long-term exposure to ambient air pollution that contains fine 
particulate matter is associated with an elevated risk of mortality (40-42). Nevertheless, 
there is remaining uncertainty about the role of chemistry versus size of the particles and 
the role of the various constituents of ambient air pollution. 
It is not clear that the case-crossover design is necessarily superior or inferior to 
the various advanced time-series approaches. Yet, the case-crossover design does 
contribute further evidence that the associations between daily mortality and ambient air 
pollution are relatively robust and are probably not due to methodologic bias or 
confounding by day of week, seasonality, long-term time trends, or weather variables. It 
is evident that future epidemiological studies will need to focus on elucidating the 
interplay between ambient air pollutants and biological mechanisms that lead to adverse 
effects on human health.  
 
Exposure assessment methodologies 
 
In most epidemiological studies that investigate the effects of ambient air 
pollution on human health, concentrations are measured at one or a few fixed monitoring 
stations and the result of the measurements are used to characterize daily variation in 
exposure for a whole population. Such exposure measurements are suited for time series 
studies of short-term health effects. When it comes to studies of long-term health effects 
of ambient air pollution there is a need for methods that can measure or estimate long-
term exposure within a population at a more individual level.  
 In general, there is a lack of data on ambient air pollutants. Therefore, new 
methods have been developed to estimate concentrations of ambient air pollutants. 
Information on emissions, topography, meteorology and ambient air pollution has lead to 
the development of mathematical models for estimating ambient air pollution exposure at 
different locations and time intervals in a geographical area. Such models, often 
incorporated into geographical information systems, are now used for surveillance of 
ambient air pollution in many urban areas. A geographical information system is a 
collection of computer hardware, software, and geographic data for capturing, managing,  
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analyzing and displaying different forms of geographically referenced information (64).  
These models have the potential to estimate ambient air pollution exposure  
retrospectively and for studies of the relation between ambient air pollution and chronic 
health effects. For calculating long-term concentrations (months to years), Gaussian 
Diffusion Models have been used for many years. Such models use frequencies of 
different winds and stability, and are based upon homogeneous stationary conditions. In 
general, they overestimate concentrations but adjustments in the models give results 
surprisingly close to measurements (65). 
 Recently, the Norwegian Institute for Air Research (NILU) developed an air 
dispersion model, based on a geographical information system, for assessing ambient air 
pollution levels in Oslo, Norway. The model was developed to describe residential 
ambient air pollution levels for the population, and to enable assessment of the health 
effects of long-term air exposure during the same period. It has been used to estimate 
residential ambient air pollution for a cohort of 16,209 men living in Oslo. This 
information has been linked with information on cancer development from the 
Norwegian Cancer Register in order to estimate associations between long-term exposure 
to ambient air pollution and the development of lung cancer (66).   
 
Biological methodologies 
 
Epidemiological study designs have been used to identify biological mechanisms.  
However, much uncertainty exists with regard to the biologic plausibility of associations 
from epidemiological studies. Biologic plausibility is enhanced by the observation of a 
coherent cascade of cardiopulmonary health effects and by the fact that non-
cardiopulmonary health end points are not typically associated with ambient air pollution.  
A review of the literature (4, 29-34) reveals that numerous cardiopulmonary health 
endpoints have been observed to be associated with day-to-day changes in ambient air 
pollution. In addition to cardiopulmonary mortality, some constituents of ambient air 
pollution have been associated with emergency room and physician's office visits for 
asthma and other respiratory disorders, hospital admissions for cardiopulmonary disease, 
increased reported respiratory symptoms, and decreased lung function. Recently, studies 
have attempted to assess specific physiologic endpoints, in addition to lung function, such  
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as plasma viscosity (67), hypoxemia and heart rate (68, 69), heart rate variability (70, 71), 
and acute inflammatory responses (72, 73). Nonetheless, more research on the  
pathophysiologic mechanisms linking cardiopulmonary mortality, morbidity, and 
ambient air pollution needs to be done.  
 Many studies investigating the effects of ambient air pollution on human health 
have mainly relied on spirometric tests to measure changes in lung function, self-reported 
symptoms, or hospital admissions or mortality due to respiratory diseases (74, 75). The 
effects of ambient air pollution on the respiratory system have been investigated and 
documented using a variety of indicators and tests, including invasive medical procedures 
such as bronchoalveolar lavage (BAL) and bronchial biopsy. Currently, most medical 
investigations of inflammation or injury to the respiratory system rely upon BAL and 
bronchial biopsy. However, the invasive nature of BAL and bronchial biopsy is not 
appropriate for monitoring populations exposed to air pollutants in the environment or 
workplace because they demand a lot of time and resources. Furthermore, for ethical and 
practical reasons, BAL and bronchial biopsy cannot be used for assessing health risks in 
children and patients with compromised cardiopulmonary function who are the most 
vulnerable to ambient air pollutants. More importantly, ambient air pollutants can 
produce effects on the pulmonary epithelium that are underestimated or even undetected 
by BAL and bronchial biopsy (76).  
One of the earliest clinical manifestations of lung inflammation and injury is an 
increased permeability of the lung epithelium, which is the main barrier hindering the 
bidirectional air-blood flux of proteins (77). Until recently, this increased permeability 
could be confirmed only by measuring the leakage of plasma proteins into the epithelial 
lining fluid sampled by BAL. Recent research in the field of biomarkers offers new 
opportunities with the development of molecular tools to measure non-invasively the 
extent of lung inflammation or injury. Methods for analyzing biomarkers in exhaled air or 
exhaled breath condensate have recently become available to monitor airway 
inflammation and injury. One of the most validated tests consists of measuring nitric 
oxide in exhaled air (eNO), a test that has increasingly proved to be a reliable measure of 
inflammation and oxidative stress in the bronchial epithelium (78).  
More recently, a new approach referred to as, "pneumoproteinemia" was 
developed to evaluate the integrity of the pulmonary epithelium by measuring the 
concentration of lung-specific proteins in serum. The prototypic pneumoprotein is the  
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16-kDa Clara cell protein (CC16), an anti-inflammatory protein secreted by Clara cells in 
the respiratory tract and predominately in terminal bronchioles from where it leaks into  
serum (79, 80). Serum CC16 concentrations for healthy nonsmokers have been measured 
and range from 10-15 µg/L, which is about 10,000 times lower than in epithelial lining 
fluid. This huge concentration gradient most likely provides the driving force for the 
diffusion of CC16 from the lung into the blood. Because of its short half-life of 
approximately two to three hours, it has been hypothesized that CC16 in serum more 
accurately reflects the time course of ambient air pollutant-induced permeability changes 
than plasma proteins in BAL (81).  
In human and experimental animal studies, it has been demonstrated that the 
serum concentration of CC16 is a sensitive biomarker to detect an increased permeability 
of the bronchoalveolar-blood barrier, which is one of the earliest signs of lung injury 
induced by ambient air pollutants (74, 76, 82, 83). Several ambient air pollutants have 
been observed to be associated with either increases or decreases in serum CC16 
concentrations. However, it is important to be cognizant of the fact that serum CC16 
concentrations can increase by a disruption of the epithelial barrier and decrease 
following a destruction of Clara cells. For example, serum CC16 concentrations have 
been shown to increase with acute lung injury involving disruption of the 
bronchoalveolar-blood barrier. Increases have been associated with smoke inhalation 
among firefighters (75), trichloramine among regular indoor-chlorinated swimming pool 
attendees (82, 84), and acute exposures to ambient air pollution, including ozone, PM2.5, 
PM10, and NO2 (76, 85, 87). Conversely, serum CC16 concentrations have been shown to 
decrease with chronic exposures. Decreases have been associated with smoking (85) and 
occupational exposures to nitric oxides (83), and silica (86).  
 
Justification for this study 
 
Currently, there is a paucity of studies that specifically explore associations 
between serum CC16 concentrations in elderly populations and exposures to ambient air 
pollutants. To explore associations between ambient air pollutants and serum 
concentrations of CC16 among elderly men in Oslo, Norway a cross-sectional study 
design was selected. This method was mainly chosen because statistical analyses for this 
thesis project focus on a sub-sample taken from a prospective cohort study. Essentially,  
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this study is a "snapshot" of a cohort with information on health outcomes and exposures 
determined simultaneously for each subject. Also, cross-sectional analyses tend to be  
less expensive and require less time compared to cohort studies. Moreover, they have an 
advantage over time-series analyses in that they can capture both acute and chronic 
effects of ambient air pollution.     
This study used data collected during the second round of the Oslo Study (Oslo 
Study II), a health study of 7,157 men between the ages of 67 and 77 years of age from 
the city of Oslo. The data collection occurred from January to June 2000 and included 
questionnaires and a basic clinical examination. The basic clinical examination included 
measurements of blood pressure and pulse, as well as the collection of venous non-fasting 
blood samples. 
To determine serum CC16 concentrations, the main outcome or dependent 
variable of this study, 1200 blood samples from the Oslo Study II were tested during 
March and April 2006, using an enzyme-linked immunosorbent assay from BioVender 
Laboratory Medicine (Brno, Czech Republic), according to the protocol provided by the 
manufacturer. All analyses were performed in duplicate. Calibrator samples and quality 
control samples were included in each assay to control for performance and interassay 
variability.  
To assess both short-term and long-term exposures to ambient air pollution, I used 
estimates from the Air Quality Information System (AirQUIS-EPISODE) model 
developed at The Norwegian Institute of Air Research (NILU). Indicators of ambient air 
pollution exposure at each participant's home address included nitrogen dioxide (NO2), 
particulate matter with aerodynamic diameter <2.5 µg/m
3
 (PM2.5), and particulate matter 
with aerodynamic diameter <10 µg/m
3
 (PM10).  
One of the major constraints of cross-sectional studies is the need to account for a 
large number of potentially confounding factors, such as differences in age, level of 
education, personal smoking status, number of cigarettes smoked daily, and chronic 
bronchitis and/or emphysema. To address this limitation, I used data on these 
independent variables from the Oslo Study II questionnaires and the basic clinical 
examination. These variables were included in the statistical analyses.  
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4. STUDY OBJECTIVES 
  
4.1. Main objective 
 
The main objective of this research project is to investigate associations between serum 
CC16 concentrations, among a population of elderly men in Oslo, Norway, and 
exposures to ambient air pollutants. 
 
4.2. Specific objectives 
 
1. Assess the prevalence of exposure to ambient air pollutants [nitrogen dioxide 
(NO2), course particulate matter with an aerodynamic diameter less than 10 µm 
(PM10), and fine particulate matter with an aerodynamic diameter less than 2.5 µm 
(PM2.5)], among a population of elderly men in Oslo, Norway. 
2. Assess the prevalence of exposure to selected environmental factors; other than 
NO2, PM10, and PM2.5, among a population of elderly men in Oslo, Norway. 
3. Assess the association between serum CC16 concentrations, among a population 
of elderly men in Oslo, Norway, and selected ambient air pollutants and 
environmental exposures. 
4. Assess the relationship between serum CC16 concentrations and selected ambient 
air pollutants, while adjusting for covariates. 
 
5. STUDY DESIGN 
 
Cross sectional study 
 
A cross-sectional study design was employed for investigating associations between 
ambient air pollutants; specifically, NO2, PM10, PM2.5, and serum CC16 concentrations 
among a population of elderly men living in Oslo, Norway.    
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6. METHODOLOGY 
 
The following section describes the methodology that was employed for this study. 
 
6.1. Variables 
 
 
Serum CC16 concentrations  
 
Serum CC16 concentrations were determined by enzyme-linked immunosorbent assay, 
according to the manufacturer's standard protocol (BioVendor; www.biovendor.com).  
However, phosphate-buffered saline was used as a buffer instead of Tris-buffered saline, 
and the assay dilution buffer was supplemented with 0.5 percent bovine serum albumin.  
In addition, antibody concentrations were lowered to 1.0 and 0.2 µg/ml for the capture 
and detection antibodies, respectively. Absorbance was measured and quantified using a 
plate reader (TECAN Sunrise, Phoenix Research Products, Hayward, CA, USA) 
complete with software (Magellan V 1.10) 
 
 
Variables Method of verification Scale of measurement 
1.  Serum Clara cell protein The Norwegian Institute of Public Health µg/L 
2.  Age Oslo II study questionnaire Years 
3.  Level of education Oslo II study questionnaire Years 
4.  Personal smoking status Oslo II study questionnaire Current, past, or never 
5.  Number of cigarettes smoked daily. Oslo II study questionnaire Number of cigarettes 
6.  Chronic bronchitis/emphysema Oslo II study questionnaire Yes/No 
7. Modeled Exposure to Nitrogen 
dioxide (NO2) at participant's home 
address 
AirQUIS-EPISODE model at The 
Norwegian Institute of Air Research 
NO2 value (µg/m
3
), one week 
and one year before the basic 
clinical examination 
8. Modeled Exposure to particulate 
matter (PM2.5) at  participant's home 
address 
AirQUIS-EPISODE model at The 
Norwegian Institute of Air Research 
PM2.5 value (µg/m
3
), one week 
and one year before the basic 
clinical examination 
9. Modeled Exposure to particulate 
matter (PM10) at  participant's home 
address 
AirQUIS-EPISODE model at The 
Norwegian Institute of Air Research 
PM10 value (µg/m
3
), one week 
and one year before the basic 
clinical examination 
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Age  
 
The age of participants ranged from 67 to 77 years old.  
 
Education level 
 
Participant's education level was reported as the number of years and was recoded into 
three categories: <10 years, 10-12 years, and >12 years.   
 
Personal smoking status   
 
Each participant completed a questionnaire in which they indicated whether they were 
current smokers, ex-smokers, or non-smokers.  
 
Number of cigarettes smoked daily by current smokers 
 
Each participant completed a questionnaire in which current smokers reported the 
number of cigarettes smoked per day. This variable was recoded as follows:  0-4 per day, 
5-9 per day, 10-14 per day, 15-19 per day, and 20 or more per day.   
 
Chronic bronchitis and/or emphysema 
 
Each participant completed a questionnaire in which participants self-reported 
experiencing (yes or no) chronic bronchitis and/or emphysema. 
 
Ambient air pollution exposure 
 
Ambient air pollution (NO2, PM10, PM2.5) concentrations (µg/m
3
) at the participant's 
home were estimated using the Air Quality Information System (AirQUIS-EPISODE) 
model (www.nilu.no/airquis) that was developed at the Norwegian Institute of Air 
Research (NILU). AirQUIS-EPISODE is an air dispersion model based on a geographical 
information system (GIS), which estimates the concentrations of NO2, PM10 and PM2.5, 
based on hourly measurements of ambient air pollutants and meteorological data 
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recorded at regional monitoring stations. The main sources of NO2, PM10, PM2.5 during 
the study period were traffic exhaust, road dust, wood burning, and long-range transport 
(54, 55, 88).  
    
6.2. Selection and study population 
 
6.2.1. Study site and population  
 
Norway is located on the western portion of the Scandinavian Peninsula, with a land area 
of 323,802 square kilometers and a population of approximately 4.7 million. Norway is 
composed of 19 counties and 431 municipalities. 
 
6.2.2. Study area 
 
The data collection for this thesis research project took place in Oslo, the capital of 
Norway. Oslo is both a county and a municipality. Oslo is the largest city in Norway with 
an estimated 560,000 residents. Norway's renowned population-based databases in are 
highly advantageous for epidemiological research. The National Population Register 
(Skattedirektoratet, Oslo, Norway) collects information on home addresses for all 
Norwegians and is updated each month. The Norwegian Institute for Air Research has 
estimated average concentrations of ambient air pollutants (NO2, PM10, PM2.5) at the 
home address of all participants.        
 
6.2.3. Study population 
 
The study population for this research project was selected from the Oslo Study II, a 
follow-up health screening of the Oslo Study I, which was a cohort study that 
investigated the epidemiological aspects of cardiovascular diseases among a population 
of men living in Oslo. The follow-up health screening, conducted from January to June 
2000, evaluated 7,157 men between 67 and 77 years of age and living in Oslo. Two 
weeks prior to the health screening appointment, a letter of invitation including two 
confidential questionnaires, a 4-page main questionnaire and a 2-page supplementary  
questionnaire were mailed to these men. The questionnaires included questions about 
age, weight, height, smoking history, alcohol use, occupation, diet, education, marital  
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status, physical activity, and other characteristics (Division of Epidemiology, Norwegian 
Institute of Public Health, Oslo, Norway). During the health screening, the questionnaires 
were turned in; all participants signed a letter of consent; and blood samples were 
obtained and stored at -20 degrees Celsius for research purposes. About two weeks after 
participating in the health screening, participants received feedback about their height, 
weight, body mass index, blood pressure, total serum cholesterol, HDL-cholesterol, 
triglycerides, and glucose. 
 
6.3. Data collection 
 
Data for this study was collected during the Oslo Study II from January to June 2000.  
During March and April 2006, an enzyme-linked immunosorbent assay (ELISA) was 
used to determine serum CC16 concentrations for 1200 blood samples that were drawn 
during the Oslo Study II. These 1200 blood samples had been stored in -20 degrees 
Celsius freezers. The 1200 blood samples were selected based on the mean NO2 
concentration at each participant's home address during the last year before the basic 
clinical examination. These 1200 blood samples were selected from the total blood 
samples collected in the following manner: 400 were randomly picked from the bottom 
25 percent quartile, another 400 were selected from the 25 to 50 and 50 to 75 percent 
quartiles, and the last 400 were selected from top 25 percent quartile. All data were 
entered into a SPSS dataset, which is maintained by Norway's Institute of Public Health. 
 
6.4. Data handling 
 
Data cleaning was performed to limit the statistical analyses to cases with complete 
information on the Oslo Study II attendance variable (year, month, day, and hour) and the 
variables of interest (n = 1014). The distribution of serum concentrations was positively 
skewed so a log transformation of this variable was performed.   
 
6.5. Data analysis 
 
The data analyses included descriptive statistics, bivariate Spearman correlations, and 
linear regression models to estimate the effect of ambient air pollutants on the percent  
change in the concentration of serum Clara cell protein, while adjusting for other 
covariates. Statistical analyses were conducted using SPSS version 16 (SPSS Inc., 
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Chicago, IL, USA). One-way analysis of variance (ANOVA) was used to test for 
differences in means between groups, and to look for trends across categorical variables.  
The linear regression analyses were performed with both continuous and categorical 
variables.   
 
6.5.1. Hypothesis testing 
 
Ha: There is an association between serum CC16 concentrations and exposures to NO2 that 
occurred one-week before the basic clinical examination. 
Ha: There is an association between serum CC16 concentrations and exposures to PM2.5 that 
occurred one-week before the basic clinical examination. 
Ha: There is an association between serum CC16 concentrations and exposures to PM10 that 
occurred one-week before the basic clinical examination. 
Ha: There is an association between serum CC16 concentrations and exposures to NO2 that 
occurred one-year before the basic clinical examination. 
Ha: There is an association between serum CC16 concentrations and exposures to PM2.5 that 
occurred one-year before the basic clinical examination. 
Ha: There is an association between serum CC16 concentrations and exposures to PM10 that 
occurred one-year before the basic clinical examination. 
Ho: There is no association between CC16 serum concentrations and exposures to NO2 that 
occurred one-week before the basic clinical examination. 
Ho: There is no association between CC16 serum concentrations and exposures to PM2.5 that 
occurred one-week before the basic clinical examination. 
Ho: There is no association between CC16 serum concentrations and exposures to PM10 that 
occurred one-week before the basic clinical examination. 
Ho: There is no association between CC16 serum concentrations and exposures to NO2 that 
occurred one-year before the basic clinical examination. 
Ho: There is no association between CC16 serum concentrations and exposures to PM2.5 that 
occurred one-year before the basic clinical examination. 
Ho: There is no association between CC16 serum concentrations and exposures to PM10 that 
occurred one-year before the basic clinical examination. 
 
 
 
 26
 
7. RESULTS 
 
Descriptive statistics 
 
Descriptive statistics for the study population are presented in Table 1. Unadjusted serum 
CC16 concentrations ranged from 1.2 to 115.2 µg/L with a geometric mean of 9.4 µg/L.  
The study population included elderly men aged 67 to 77 years, with a mean age of 70.7 
years. About five percent of participants reported experiencing chronic bronchitis and/or 
emphysema. The study sample consisted of 16.9 percent current smokers, 54 percent 
former smokers, and 29.1 percent non-smokers. Descriptive statistics for participant's 
exposures to NO2, PM10, and PM2.5 (one-week before the basic clinical examination) are 
presented in Table 2.     
 
Bivariate Spearman correlation analyses 
 
A summary of the bivariate Spearman correlation analyses is presented in Table 3. Age 
was significantly associated with logCC16 (p < 0.01). Education was not significantly  
associated with logCC16 (p = 0.346). Chronic bronchitis and/or emphysema were 
significantly associated with logCC16 (p < 0.01). Smoking status was significantly 
associated with logCC16 (p < 0.01). Number of cigarettes smoked per day was 
significantly associated with logCC16 (p < 0.01). N02, PM10, and PM2.5 exposures that  
occurred one-year before the basic clinical examination were not significantly associated 
with logCC16 (p = 0.344, 0.995, 0.793, respectively). NO2 exposures that occurred one-
week before the basic clinical examination were not significantly associated with 
logCC16 (p = 0.330). PM10 and PM2.5 exposures that occurred one-week before the basic  
clinical examination were significantly associated with logCC16 (p = 0.005 and 0.002, 
respectively).   
 
One-way analysis of variance (ANOVA) analyses  
 
Results of the one-way analysis of variance (ANOVA) analyses are described below. 
 
The average concentration of serum CC16 was lower among participants who reported 
having or have had bronchitis and/or emphysema (7.53 µg/L (95 percent CI: 6.34 µg/L, 
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8.93 µg/L) compared to participants who did not report that they did not have chronic 
bronchitis and/or emphysema 9.55 µg/L (95 percent CI: 9.22µg/L, 9.88µg/L). This 
difference was statistically significant (p < 0.01). However, this difference was not 
statistically significant after adjusting for smoking status in a linear regression model 
where logCC16 was the dependent variable and bronchitis and/or emphysema and 
smoking status were the independent variables (P > 0.05). 
 
The average concentration of serum CC16 was significantly different between current, 
former, and non-smokers (p < 0.001). The average concentration of serum CC16 was 
lower among current smokers, 6.97 µg/L (95 percent CI: 6.43 µg/L, 7.57 µg/L) compared 
to former smokers, 9.66 µg/L (95 percent CI: 9.23 µg/L, 10.11 µg/L) and non-smokers, 
10.74 µg/L (95 percent CI: 10.12 µg/L, 11.39 µg/L).   
 
Generally, the average concentration of serum CC16 declined with increased numbers of 
cigarettes smoked per day. For example, the average concentration of serum CC16 was  
8.06 µg/L (95 percent CI: 7.38 µg/L, 8.81 µg/L) for participants who smoked 16-20 
cigarettes per day, compared to 9.27 µg/L (95 percent CI: 8.66 µg/L, 9.93 µg/L) among 
participants who smoked 6-10 cigarettes, and 10.61 µg/L (95 percent CI: 10.05 µg/L, 
11.21 µg/L) among participants who smoked 0-1 cigarette per day. This difference was 
statistically significant (p < 0.001).  
 
Linear regression analyses  
 
Results of the linear regression analyses are described below and in Tables 4 and 5. 
 
The percentage change in serum CC16 concentration was 0.2 percent for each 1 µg/m
3 
change in PM10 exposure that occurred one-week before the basic clinical examination, 
after adjusting for age, self-reported chronic bronchitis and/or emphysema, smoking 
status, and number of cigarettes smoked per day (p < 0.05). In addition, the percentage 
change in serum CC16 concentration was also 0.2 percent for each 1 µg/m
3 
change in  
PM2.5 exposure that occurred one-week before the basic clinical examination, after 
adjusting for age, self-reported chronic bronchitis and/or emphysema, smoking status, 
and number of cigarettes smoked per day (p < 0.01).  
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Compared to current smokers who reported smoking between 0 and 4 cigarettes per day, 
the percentage change in serum CC16 concentration was -10.1 percent for current 
smokers who reported smoking between 5 and 9 cigarettes per day, after adjusting for 
age, self-reported chronic bronchitis and/or emphysema (p < 0.01). Compared to current 
smokers who reported smoking between 0 and 4 cigarettes per day, the percentage 
change in serum CC16 concentration was -14.6 percent for current smokers who reported 
smoking between 10 and 14 cigarettes per day, after adjusting for age, self-reported 
chronic bronchitis and/or emphysema (p < 0.01). Compared to current smokers who 
reported smoking between 0 and 4 cigarettes per day, the percentage change in serum 
CC16 concentration was -15.8 percent for current smokers who reported smoking 
between 15 and 19 cigarettes per day, after adjusting for age, self-reported chronic 
bronchitis and/or emphysema (p < 0.01). Compared to current smokers who reported 
smoking between 0 and 4 cigarettes per day, the percentage change in serum CC16 
concentration was -17.8 percent for current smokers who reported smoking 20 or more  
cigarettes per day, after adjusting for age, self-reported chronic bronchitis and/or 
emphysema (p < 0.01).   
 
 8. DISCUSSION 
 
8.1. Findings 
 
Currently, there is a paucity of studies that specifically explore associations between 
serum CC16 concentrations in elderly populations and exposures to ambient air 
pollutants. Therefore, the main objective of this thesis research project is to bridge this 
gap in the literature by investigating associations between serum CC16 concentrations, 
among a population of elderly men in Oslo, Norway, and exposures to ambient air 
pollutants. 
 
In this present study, statistically significant associations were found between serum 
CC16 concentrations and the following: age; chronic bronchitis and/or emphysema; 
smoking status; number of cigarettes smoked per day; as well as PM10 and PM2.5 
exposures one-week before the basic clinical examination. 
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No associations were found between serum CC16 concentrations and the following: 
education level; and NO2, PM10 and PM2.5 exposures one-year before basic clinical 
examination.  
 
The relationship between serum CC16 concentrations and PM10 exposures one-week 
before basic clinical examination was statistically significant (p < 0.05). There was a 0.2 
percent change in serum CC16 concentrations for each one µg/m
3 
change in PM10  
exposure that occurred one-week before the basic clinical examination. This effect 
remained unchanged after adjusting for age, self-reported chronic bronchitis and/or 
emphysema, smoking status, and number of cigarettes smoked per day. In addition, the 
relationship between serum CC16 concentrations and PM2.5 exposures one-week before 
basic clinical examination was statistically significant (p < 0.01). There was a 0.2 percent 
change in serum CC16 concentrations for each one µg/m
3 
change in PM2.5  
exposure that occurred one-week before the basic clinical examination. This effect also 
remained unchanged after adjusting for age, self-reported chronic bronchitis and/or 
emphysema, smoking status, and number of cigarettes smoked per day. Thus, the effects 
on serum CC16 concentrations due to exposures to PM10 and PM2.5 that occurred one-
week before the basic clinical examination are of the same magnitude. Results of this 
study are consistent with other studies that have reported small but statistically significant 
increases in adverse health effects as a result of recent exposures to ambient air pollutants 
(17-19, 21, 35, 87).  
 
Exposure to cigarette smoke has been reported to decrease serum CC16 concentrations 
(85). Among current smokers in this study, a dose-response relationship between the 
number of cigarettes smoked per day and serum CC16 concentrations was observed. As 
the number of cigarettes smoked per day increased, serum CC16 concentrations 
decreased (Table 5). 
 
In human and experimental animal studies, it has been demonstrated that the serum 
concentration of CC16 is a sensitive biomarker to detect an increased permeability of the 
bronchoalveolar-blood barrier, which is one of the earliest signs of lung injury induced by  
ambient air pollutants (74, 76, 82, 83). Several ambient air pollutants have been observed 
to be associated with either increases or decreases in serum CC16 concentrations. Serum 
CC16 concentrations can increase by a disruption of the epithelial barrier and decrease 
 30
following a destruction of Clara cells. For example, serum CC16 concentrations have 
been shown to increase with acute lung injury involving disruption of the 
bronchoalveolar-blood barrier. Increases have been associated with smoke inhalation  
among firefighters (75), trichloramine among regular indoor-chlorinated swimming pool 
attendees (82, 84), and acute exposures to ambient air pollution, including ozone, PM2.5,  
PM10, and NO2 (76, 85, 87). Conversely, serum CC16 concentrations have been shown to 
decrease with chronic exposures. Decreases have been associated with cigarette smoking 
(85) and occupational exposures to nitric oxides (83), and silica (86). The findings of this 
study indicate that the effects of PM2.5 and PM10 exposures that occurred one-week before 
the basic clinical examination on serum CC16 concentrations are less than that of other 
known factors such as cigarette smoking. 
 
8.2. Conclusion 
 
The findings of this study are similar to other studies that have found evidence of 
associations between serum CC16 concentrations and ambient air pollutants, as well as 
other environmental exposures. In addition, results of this study are consistent with other 
studies that have reported small but statistically significant increases in adverse 
respiratory effects as a result of recent PM2.5 and PM10 exposures. Lastly, our results 
indicate that effects of PM2.5 and PM10 exposures that occurred one-week before the basic 
clinical examination on serum CC16 concentrations were less than that of other known 
factors such as cigarette smoking. 
 
However, this study has its limitations. Due to the cross-sectional study design the 
findings of this study cannot be considered causal. Despite being a rich data source, there 
is a limitation to using the Oslo Study II questionnaires, that mainly being selection bias.  
Selection bias may have had an effect on the results of this study since elderly men with 
healthy profiles may be more likely to have different health-seeking behaviors than  
elderly men who have less healthy profiles. Also, it is possible that some unknown 
confounding could affect these findings. In addition, since only a single baseline blood 
sample was taken, it was not possible to evaluate individual variation of serum CC16 
concentrations that may occur over time. Moreover, the blood samples were not taken at 
a uniform time of day, and therefore our data cannot evaluate diurnal variation in the 
individual serum CC16 concentrations. Furthermore, this study utilized self-reported  
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data, which could increase misclassification bias. It is important to be aware that these 
limitations could lead to an overestimation or underestimation of the true effects. 
 
Strengths of this study include the use of a GIS-based air dispersion model to estimate 
NO2, PM10 and PM2.5 exposures at each participant's home address; information on 
smoking and other environmental exposures is included on a large homogeneous group of 
elderly men; and serum samples have been reported to be more stable than urine samples 
for determining concentrations of CC16. 
 
In conclusion, the findings of this study support other studies that have found evidence of 
acute exposures to PM2.5 and PM10 leading to increased permeability of the 
bronchoalveolar-blood barrier in elderly men. More research is needed to gain a better 
understanding of the relationship between serum CC16 concentrations and ambient air 
pollutants, as well as other environmental exposures. Using CC16 as a non-invasive 
biomarker to assess the integrity of the respiratory epithelium could help identify 
susceptible persons with respiratory epithelial injury and bronchial dysfunction. 
Individual level information about the integrity of the respiratory epithelium in elderly 
persons could be used develop rapid risk communication strategies, so persons most at 
risk of cardiopulmonary morbidity and mortality could be warned during significant 
ambient air pollution episodes.   
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10. APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.   Descriptive statistics for the study population 
Number of subjects 1014 
Serum CC16 concentrations, mean (SD) 11.2 µg/L (8.9) 
Serum CC16 concentrations, range 1.2 to 115.2 µg/L  
Serum CC16 concentrations, geometric mean (SD) 9.4 µg/L (1.7) 
Age, years, mean (SD) 70.7 (2.8) 
Age, years, range 67 to 77 
Education, n (percent)  
          < 10 years 239 (23.6) 
         10-12 years 336 (33.1) 
          > 12 years 439 (43.3) 
Chronic bronchitis and or emphysema, n (percent)  53 (5.2) 
Smoking status, n (percent)  
          Current 171 (16.9) 
          Former 548 (54.0) 
          Never 295 (29.1) 
Number of cigarettes smoked per day by current smokers, n (percent)  
          0-4  27 (15.8) 
          5-9  46 (26.9) 
          10-14 41 (24.0) 
          15-19 24 (14.0) 
          20 or more 33 (19.3) 
  
Table 2.   Descriptive statistics for participant's exposure to NO2, PM10, & PM2.5  
Ambient air pollutants (one-week before basic clinical examination) 
  
     Based on AirQUIS-EPISODE model  
            
          NO2 µg/m
3
, mean (SD) 34.6 (15.1) 
          PM10 µg/m
3
  18.7 (10.9) 
          PM2.5 µg/m
3
 15.8 (9.5) 
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Table 3.   Summary of bivariate Spearman correlation analyses 
  p-value 
log(CC16) with:   
Age (continuous)  < 0.01 
Education (categorical)  0.346 
Chronic bronchitis and/or emphysema (categorical)  < 0.01 
Smoking status (categorical)  < 0.01 
Number of cigarettes smoked per day (categorical)  < 0.01 
NO2 exposure one-year before basic clinical examination (continuous)  0.344 
PM10 exposure one-year before basic clinical examination (continuous)  0.995 
PM2.5 exposure one-year before basic clinical examination (continuous)   0.793 
NO2 exposure one-week before basic clinical examination (continuous)  0.330 
PM10 exposure one-week before basic clinical examination (continuous)  0.005 
PM2.5 exposure one-week before basic clinical examination (continuous)   0.002 
   
 41
 
Table 4.  Associations between serum CC16 concentration and ambient air pollutant exposures; percent change (95 
percent confidence interval (CI) in serum CC16 concentration per 1 µg/m
3
 change in exposure 
 Crude change (95 percent CI) Adjusted change (95 percent CI)
‡
 
Ambient air pollutants (AirQUIS-EPISODE model)   
 PM2.5 µg/m
3 
(week before) 0.2 (0.1, 0.4) ** 0.2 (0.0, 0.3) ** 
 PM10 µg/m
3 
(week before) 0.2 (0.0, 0.3) * 0.2 (0.0, 0.3) * 
    
‡
 Adjusted for age, self-reported chronic bronchitis and/or emphysema, smoking status, number of cigarettes smoked per day.  
* p < 0.05  ** p < 0.01 
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Table 5.  Associations between serum CC16 concentrations and cigarette smoking;  
               percent change (95 percent CI) in serum CC16 concentration per level of exposure.  
      
        Crude change (95 percent CI) Adjusted change (95 percent CI) 
Number of cigarettes smoked per 
day by current smokers    
 0 – 4 cigarettes 27 reference reference 
 5 – 9 cigarettes 46 -11.2 (-18.3, -4.1) ** -10.1 (-17.1, -3.1) 
a
 ** 
 10 – 14 cigarettes 41 -15.9 (-23.4, -8.4) *** -14.6 (-22.0, -7.2) 
a 
***
 
 
 15 – 19 cigarettes 24 -16.5 (-26.2, -6.8) ** -15.8 (-25.4, -6.2) 
a
 ** 
 20 or more cigarettes 33 -19.9 (-28.1, -11.6) *** -17.8 (-26.1, -9.5) 
a
 *** 
 
a 
Adjusted for age, self-reported chronic bronchitis and/or emphysema. 
* 
p < 0.05,  ** p < 0.01, *** p < 0.001 
